Honda [49] and Zepeda [50] had confirmed that VEGF inhibitors cannot be used for stage 4 or 5 ROP because they can increase the contraction of the fibrovascular membrane and accelerate retinal detachment. Here, VEGFA is linked to retinopathy of prematurity.